# WDFY4

## Overview
WDFY4 is a gene that encodes the WDFY family member 4 protein, which is primarily involved in immune system functions. The protein is characterized by several domains, including BEACH, WD40, and FYVE, which facilitate its role in vesicle trafficking, protein localization, and cytoskeletal organization. WDFY4 is predominantly expressed in immune tissues and plays a crucial role in the process of cross-presentation, where dendritic cells present extracellular antigens on MHC class I molecules, a key mechanism in antiviral and antitumor immunity. The protein interacts with pattern recognition receptors and enhances NF-κB activation, thereby modulating immune signaling pathways. Variants of the WDFY4 gene have been associated with autoimmune diseases such as clinically amyopathic dermatomyositis and systemic lupus erythematosus, underscoring its clinical significance in immune regulation (Theisen2018WDFY4; Kochi2018Splicing; Li2021Deficiency).

## Structure
The WDFY4 protein is characterized by several distinct domains that contribute to its function. It contains two BEACH domains, six WD40 repeats, and a truncated FYVE zinc finger domain (Khani2021BVVL). The BEACH domains are involved in membrane trafficking, while the WD40 repeats are known for their roles in signal transduction, pre-mRNA processing, and cytoskeleton assembly (Khani2021BVVL). The protein also includes a pleckstrin homology (PH) domain, which is involved in protein localization and vesicle transport (Theisen2018WDFY4).

WDFY4 is a large protein with 3184 amino acid residues, and its sequence is highly conserved across species (Yang2010GenomeWide). The protein is predominantly expressed in immune tissues, such as lymph nodes, spleen, thymus, and tonsils (Yang2010GenomeWide). It interacts with pattern recognition receptors like TLR3, TLR4, TLR9, and MDA5, enhancing NF-κB activation, which is crucial for immune signaling pathways (Kochi2018Splicing).

A splicing variant of WDFY4, known as tr-WDFY4, has been identified, which affects MDA5 signaling and increases the risk of clinically amyopathic dermatomyositis (Kochi2018Splicing). This variant introduces an alternate stop codon, resulting in a truncated protein (Kochi2018Splicing).

## Function
The WDFY4 gene encodes a protein that plays a significant role in the immune system, particularly in the process of cross-presentation, which is crucial for the immune response to viral and tumor antigens. This process involves the presentation of extracellular antigens on MHC class I molecules by dendritic cells, specifically conventional dendritic cells type 1 (cDC1s) (Theisen2018WDFY4). WDFY4 is involved in subcellular vesicular targeting, interacting with proteins critical for endocytic vesicle formation and trafficking, such as clathrin and components of the AP-2 clathrin adaptor complex (Theisen2018WDFY4).

The protein is characterized by domains such as PH, BEACH, WD40, and FYVE, which are involved in protein localization, vesicle transport, and cytoskeletal organization (Theisen2018WDFY4). WDFY4 localizes near the plasma membrane and is associated with endosomal markers, suggesting its involvement in trafficking between the cell surface and endosomes (Theisen2018WDFY4). It also interacts with Hsp90ab1, a chaperone involved in antigen translocation during cross-presentation (Theisen2018WDFY4).

In addition to its role in cross-presentation, WDFY4 is implicated in the regulation of apoptosis and proliferation in CD8+ T cells, potentially through pathways involving reactive oxygen species and the p53 pathway (Li2021Deficiency).

## Clinical Significance
Mutations and alterations in the WDFY4 gene have been implicated in several autoimmune and immune-related diseases. A splicing variant of WDFY4 is associated with clinically amyopathic dermatomyositis (CADM), a condition characterized by severe lung inflammation and the presence of anti-MDA5 autoantibodies. This variant leads to a truncated isoform of the WDFY4 protein, which enhances MDA5 signaling and NF-κB activation, contributing to the pathogenesis of CADM (Kochi2018Splicing).

WDFY4 is also linked to systemic lupus erythematosus (SLE) and other autoimmune diseases. Its deficiency in CD8+ T cells results in increased apoptosis due to reactive oxygen species (ROS) production, which may contribute to immune dysregulation observed in these conditions (Li2021Deficiency).

In the context of Brown-Vialetto-Van Laere syndrome (BVVL), a mutation in WDFY4 has been identified, suggesting a potential role in the disease's immune-related pathology. This mutation may affect immune system functions, although the exact mechanisms remain unclear (Khani2021BVVL). These findings highlight the clinical significance of WDFY4 in various immune-mediated disorders.

## Interactions
WDFY4 interacts with several proteins involved in immune signaling pathways. It is known to interact with pattern recognition receptors (PRRs) such as TLR3, TLR4, TLR9, and MDA5, enhancing NF-κB activation by these receptors (Ignatieva2019Exomewide; Kochi2018Splicing). The interaction between WDFY4 isoforms and these PRRs was confirmed through coimmunoprecipitation assays, showing a strong interaction between the truncated variant tr-WDFY4 and MDA5 (Kochi2018Splicing). 

WDFY4 also plays a role in cross-presentation of antigens by conventional dendritic cells (cDC1s). It interacts with components critical for endocytic vesicle formation and trafficking, such as clathrin and the AP-2 clathrin adaptor complex, as well as modulators of cytoskeleton dynamics (Theisen2018WDFY4). WDFY4 selectively associates with Hsp90ab1, a chaperone involved in antigen translocation during cross-presentation (Barbet2018A). 

These interactions suggest that WDFY4 is involved in mediating membrane-associated functions necessary for cross-presentation and immune response modulation, highlighting its role in both innate and adaptive immunity (Theisen2018WDFY4).


## References


[1. (Khani2021BVVL) Marzieh Khani, Hosein Shamshiri, Hanieh Taheri, John Hardy, Jose Tomas Bras, Susana Carmona, Hamidreza Moazzeni, Afagh Alavi, Ali Heshmati, Peyman Taghizadeh, Yalda Nilipour, Tooba Ghazanfari, Majid Shahabi, Ali Asghar Okhovat, Mohammad Rohani, Giorgio Valle, Reza Boostani, Siamak Abdi, Shaghayegh Eshghi, Shahriar Nafissi, and Elahe Elahi. Bvvl/ fl: features caused by slc52a3 mutations; wdfy4 and tnfsf13b may be novel causative genes. Neurobiology of Aging, 99:102.e1-102.e10, March 2021. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2020.09.021, doi:10.1016/j.neurobiolaging.2020.09.021. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2020.09.021)

[2. (Kochi2018Splicing) Yuta Kochi, Yoichiro Kamatani, Yuya Kondo, Akari Suzuki, Eiryo Kawakami, Ryosuke Hiwa, Yukihide Momozawa, Manabu Fujimoto, Masatoshi Jinnin, Yoshiya Tanaka, Takashi Kanda, Robert G Cooper, Hector Chinoy, Simon Rothwell, Janine A Lamb, Jiří Vencovský, Heřman Mann, Koichiro Ohmura, Keiko Myouzen, Kazuyoshi Ishigaki, Ran Nakashima, Yuji Hosono, Hiroto Tsuboi, Hidenaga Kawasumi, Yukiko Iwasaki, Hiroshi Kajiyama, Tetsuya Horita, Mariko Ogawa-Momohara, Akito Takamura, Shinichiro Tsunoda, Jun Shimizu, Keishi Fujio, Hirofumi Amano, Akio Mimori, Atsushi Kawakami, Hisanori Umehara, Tsutomu Takeuchi, Hajime Sano, Yoshinao Muro, Tatsuya Atsumi, Toshihide Mimura, Yasushi Kawaguchi, Tsuneyo Mimori, Atsushi Takahashi, Michiaki Kubo, Hitoshi Kohsaka, Takayuki Sumida, and Kazuhiko Yamamoto. Splicing variant of wdfy4 augments mda5 signalling and the risk of clinically amyopathic dermatomyositis. Annals of the Rheumatic Diseases, 77(4):602–611, January 2018. URL: http://dx.doi.org/10.1136/annrheumdis-2017-212149, doi:10.1136/annrheumdis-2017-212149. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/annrheumdis-2017-212149)

[3. (Yang2010GenomeWide) Wanling Yang, Nan Shen, Dong-Qing Ye, Qiji Liu, Yan Zhang, Xiao-Xia Qian, Nattiya Hirankarn, Dingge Ying, Hai-Feng Pan, Chi Chiu Mok, Tak Mao Chan, Raymond Woon Sing Wong, Ka Wing Lee, Mo Yin Mok, Sik Nin Wong, Alexander Moon Ho Leung, Xiang-Pei Li, Yingyos Avihingsanon, Chun-Ming Wong, Tsz Leung Lee, Marco Hok Kung Ho, Pamela Pui Wah Lee, Yuk Kwan Chang, Philip H. Li, Ruo-Jie Li, Lu Zhang, Wilfred Hing Sang Wong, Irene Oi Lin Ng, Chak Sing Lau, Pak Chung Sham, and Yu Lung Lau. Genome-wide association study in asian populations identifies variants in ets1 and wdfy4 associated with systemic lupus erythematosus. PLoS Genetics, 6(2):e1000841, February 2010. URL: http://dx.doi.org/10.1371/journal.pgen.1000841, doi:10.1371/journal.pgen.1000841. This article has 348 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000841)

[4. (Ignatieva2019Exomewide) Elena V. Ignatieva, Andrey A. Yurchenko, Mikhail I. Voevoda, and Nikolay S. Yudin. Exome-wide search and functional annotation of genes associated in patients with severe tick-borne encephalitis in a russian population. BMC Medical Genomics, May 2019. URL: http://dx.doi.org/10.1186/s12920-019-0503-x, doi:10.1186/s12920-019-0503-x. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-019-0503-x)

[5. (Theisen2018WDFY4) Derek J. Theisen, Jesse T. Davidson, Carlos G. Briseño, Marco Gargaro, Elvin J. Lauron, Qiuling Wang, Pritesh Desai, Vivek Durai, Prachi Bagadia, Joshua R. Brickner, Wandy L. Beatty, Herbert W. Virgin, William E. Gillanders, Nima Mosammaparast, Michael S. Diamond, L. David Sibley, Wayne Yokoyama, Robert D. Schreiber, Theresa L. Murphy, and Kenneth M. Murphy. Wdfy4 is required for cross-presentation in response to viral and tumor antigens. Science, 362(6415):694–699, November 2018. URL: http://dx.doi.org/10.1126/science.aat5030, doi:10.1126/science.aat5030. This article has 231 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aat5030)

[6. (Li2021Deficiency) Yan Li, Jiangxia Li, Qianqian Yuan, Xianli Bian, Feng Long, Ruonan Duan, Fei Gao, Shang Gao, Shijun Wei, Anran Wang, Ai Liu, Xi Li, Wenjie Sun, and Qiji Liu. Deficiency in wdfy4 reduces the number of cd8+ t cells via reactive oxygen species-induced apoptosis. Molecular Immunology, 139:131–138, November 2021. URL: http://dx.doi.org/10.1016/j.molimm.2021.08.022, doi:10.1016/j.molimm.2021.08.022. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2021.08.022)

[7. (Barbet2018A) Gaëtan Barbet and J. Magarian Blander. A key ingredient for priming killer t cells. Science, 362(6415):641–642, November 2018. URL: http://dx.doi.org/10.1126/science.aav3683, doi:10.1126/science.aav3683. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aav3683)